[go: up one dir, main page]

WO2002041829A3 - Distribution orale de nanospheres - Google Patents

Distribution orale de nanospheres Download PDF

Info

Publication number
WO2002041829A3
WO2002041829A3 PCT/US2001/043299 US0143299W WO0241829A3 WO 2002041829 A3 WO2002041829 A3 WO 2002041829A3 US 0143299 W US0143299 W US 0143299W WO 0241829 A3 WO0241829 A3 WO 0241829A3
Authority
WO
WIPO (PCT)
Prior art keywords
oral
nanosphere delivery
delivery
nanosphere
chemotherapeutic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2001/043299
Other languages
English (en)
Other versions
WO2002041829A2 (fr
Inventor
James M Dunn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PR Pharmaceuticals Inc
Original Assignee
PR Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PR Pharmaceuticals Inc filed Critical PR Pharmaceuticals Inc
Priority to AU2002239279A priority Critical patent/AU2002239279A1/en
Priority to CA002429254A priority patent/CA2429254A1/fr
Publication of WO2002041829A2 publication Critical patent/WO2002041829A2/fr
Publication of WO2002041829A3 publication Critical patent/WO2002041829A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5138—Organic macromolecular compounds; Dendrimers obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • A61K9/5153—Polyesters, e.g. poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin

Landscapes

  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Optics & Photonics (AREA)
  • Physics & Mathematics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

L'invention concerne des préparations pharmaceutiques orales nanoparticulaires et des méthodes afférentes destinées à la libération régulée d'agents macromoléculaires et/ou chimiothérapeutiques.
PCT/US2001/043299 2000-11-20 2001-11-20 Distribution orale de nanospheres Ceased WO2002041829A2 (fr)

Priority Applications (2)

Application Number Priority Date Filing Date Title
AU2002239279A AU2002239279A1 (en) 2000-11-20 2001-11-20 Oral nanosphere delivery
CA002429254A CA2429254A1 (fr) 2000-11-20 2001-11-20 Distribution orale de nanospheres

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25207000P 2000-11-20 2000-11-20
US60/252,070 2000-11-20

Publications (2)

Publication Number Publication Date
WO2002041829A2 WO2002041829A2 (fr) 2002-05-30
WO2002041829A3 true WO2002041829A3 (fr) 2002-07-18

Family

ID=22954465

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2001/043299 Ceased WO2002041829A2 (fr) 2000-11-20 2001-11-20 Distribution orale de nanospheres

Country Status (3)

Country Link
AU (1) AU2002239279A1 (fr)
CA (1) CA2429254A1 (fr)
WO (1) WO2002041829A2 (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002036169A2 (fr) * 2000-10-31 2002-05-10 Pr Pharmaceuticals, Inc. Methodes et compositions pour ameliorer l'administration de molecules bioactives
JP2006522816A (ja) 2003-04-11 2006-10-05 ピーアール ファーマシューティカルズ， インコーポレイテッド 部位特異的タンパク質結合体を調製する方法
EP1774971A1 (fr) * 2005-10-14 2007-04-18 Advanced in Vitro Cell Technologies, S.L. Nanoparticules comprenant de chitosane et d'héparine
EP1834636A1 (fr) * 2006-03-08 2007-09-19 Sahajanand Medical Technologies PVT. ltd Compositions comprenant des articles poreux et leurs utilisations dans des dispositifs médicaux implantables
ES2310122B1 (es) 2007-04-20 2009-10-30 Instituto Cientifico Y Tecnologico De Navarra, S.A Nanoparticulas que comprenden una ciclodextrina y una molecula biologicamente activa y sus aplicaciones.
EP2105129B1 (fr) * 2008-03-24 2018-01-17 Intervet International B.V. Vaccins encapsulés pour la vaccination orale et la stimulation des poissons et autres animaux
US8778384B2 (en) 2008-03-24 2014-07-15 Advanced Bionutrition Corporation Compositions and methods for encapsulating vaccines for the oral vaccination and boostering of fish and other animals
EP2153821A1 (fr) * 2008-08-06 2010-02-17 BioAlliance Pharma Formules orales de dérivés de camptothécine

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6117455A (en) * 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent

Also Published As

Publication number Publication date
AU2002239279A1 (en) 2002-06-03
CA2429254A1 (fr) 2002-05-30
WO2002041829A2 (fr) 2002-05-30

Similar Documents

Publication Publication Date Title
AU2002357012A1 (en) Oral pharmaceutical formulations comprising paclitaxel, derivatives and methods of administration thereof
AU2001232337A1 (en) Pharmaceutical composition, reagent and method for intracerebral delivery of pharmaceutically active ingredient or labeling substance
AU2001226029A1 (en) Pharmaceutical formulation and method for pulmonary and oral delivery
EP1246608A4 (fr) Formulations pharmaceutiques pour l'administration de medicaments ayant une faible solubilite aqueuse
AU2003229084A1 (en) Methods and formulations for the delivery of pharmacologically active agents
AU2002366042A1 (en) Solid dispersions containing substituted cyclodextrin and insoluble drug and their preparations
AU2001235009A1 (en) Drug delivery apparatus
AU2001283563A1 (en) Oral pharmaceutical dosage forms for pulsatile delivery of an antiarrhythmic agent
AU2001231000A1 (en) Dry powder formulations of antihistamine for nasal administration
AU2879100A (en) Formulation and system for intra-oral delivery of pharmaceutical agents
AU3403201A (en) Drug delivery device and method
AU2001233543A1 (en) Carrier particles for drug delivery and process for preparation
HUP0104687A3 (en) Methods for preparing coated drug particles and pharmaceutical formulations thereof
AU2001238346A1 (en) Modification of biopolymers for improved drug delivery
HUP0302193A3 (en) 1,4-diazabicyclo[3.2.2]nonabenzoxazole, -benzothiazole and benzimidazole derivatives, preparation thereof and pharmaceutical compositions containing them
AU2001285481A1 (en) Apparatus and method for delivery of drugs or gene therapy vasculature
AU7594900A (en) Pharmaceutical formulations containing poorly soluble drug substances
AU2003246567A1 (en) Administration form for the oral administration of active substances, vitamins, and/or nutrients
AU2001272314A1 (en) Oral formulations for localized colonic release and the method of preparation thereof
WO2002041829A3 (fr) Distribution orale de nanospheres
AU2001276831A1 (en) Delivery vehicle composition and methods for delivering antigens and other drugs
AU2001230898A1 (en) Formulations and methods for administration of pharmacologically or biologicallyactive compounds
WO2005009407A3 (fr) Formulations pharmaceutiques d'olanzapine administrees par voie orale
AU2001228810A1 (en) Benzene-fused heterocycle derivatives and drugs containing the same as the active ingredient
AU1912501A (en) Water-soluble powders for oral solution and use thereof

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2429254

Country of ref document: CA

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP